Literature DB >> 18165275

Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.

Sameer Jhavar1, Alison Reid, Jeremy Clark, Zsofia Kote-Jarai, Timothy Christmas, Alan Thompson, Christopher Woodhouse, Christopher Ogden, Cyril Fisher, Cathy Corbishley, Johann De-Bono, Rosalind Eeles, Daniel Brewer, Colin Cooper.   

Abstract

Translocation of TMPRSS2 to the ERG gene, found in a high proportion of human prostate cancer, results in overexpression of the 3'-ERG sequences joined to the 5'-TMPRSS2 promoter. The studies presented here were designed to test the ability of expression analysis on GeneChip Human Exon 1.0 ST arrays to detect 5'-TMPRSS2-ERG-3' hybrid transcripts encoded by this translocation. Monitoring the relative expression of each ERG exon revealed altered transcription of the ERG gene in 15 of a series of 27 prostate cancer samples. In all cases, exons 4 to 11 exhibited enhanced expression compared with exons 2 and 3. This pattern of expression indicated that the most abundant hybrid transcripts involve fusions to ERG exon 4, and RT-PCR analyses confirmed the joining of TMPRSS2 exon 1 to ERG exon 4 in all 15 cases. The exon expression patterns also indicated that TMPRSS2-ERG fusion transcripts commonly contain deletion of ERG exon 8. Analysis of gene-level data from the arrays allowed the identification of genes whose expression levels significantly correlated with the presence of the translocation. These studies demonstrate that expression analyses using exon arrays represent a valuable approach for detecting ETS gene translocation in prostate cancer, in parallel with analyses of gene expression profiles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165275      PMCID: PMC2175543          DOI: 10.2353/jmoldx.2008.070085

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  19 in total

1.  Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Alex Smith; Michael W Kattan; Jaya Satagopan; Victor E Reuter; Peter T Scardino; William L Gerald
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

2.  Linear models and empirical bayes methods for assessing differential expression in microarray experiments.

Authors:  Gordon K Smyth
Journal:  Stat Appl Genet Mol Biol       Date:  2004-02-12

3.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Authors:  Sooryanarayana Varambally; Jianjun Yu; Bharathi Laxman; Daniel R Rhodes; Rohit Mehra; Scott A Tomlins; Rajal B Shah; Uma Chandran; Federico A Monzon; Michael J Becich; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

4.  TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

Authors:  Karin G Hermans; Ronald van Marion; Herman van Dekken; Guido Jenster; Wytske M van Weerden; Jan Trapman
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Lisa R Smith; Diane Roulston; Beth E Helgeson; Xuhong Cao; John T Wei; Mark A Rubin; Rajal B Shah; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

6.  TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.

Authors:  Kristiina Iljin; Maija Wolf; Henrik Edgren; Santosh Gupta; Sami Kilpinen; Rolf I Skotheim; Mari Peltola; Frank Smit; Gerald Verhaegh; Jack Schalken; Matthias Nees; Olli Kallioniemi
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Defining aggressive prostate cancer using a 12-gene model.

Authors:  Tarek A Bismar; Francesca Demichelis; Alberto Riva; Robert Kim; Sooryanarayana Varambally; Le He; Jeff Kutok; Jonathan C Aster; Jeffery Tang; Rainer Kuefer; Matthias D Hofer; Phillip G Febbo; Arul M Chinnaiyan; Mark A Rubin
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

8.  Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.

Authors:  Paul J Gardina; Tyson A Clark; Brian Shimada; Michelle K Staples; Qing Yang; James Veitch; Anthony Schweitzer; Tarif Awad; Charles Sugnet; Suzanne Dee; Christopher Davies; Alan Williams; Yaron Turpaz
Journal:  BMC Genomics       Date:  2006-12-27       Impact factor: 3.969

9.  Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development.

Authors:  M Iwamoto; Y Higuchi; E Koyama; M Enomoto-Iwamoto; K Kurisu; H Yeh; W R Abrams; J Rosenbloom; M Pacifici
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

10.  Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.

Authors:  A J Crew; J Clark; C Fisher; S Gill; R Grimer; A Chand; J Shipley; B A Gusterson; C S Cooper
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  28 in total

1.  Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.

Authors:  Jung H Kim; Saravana M Dhanasekaran; John R Prensner; Xuhong Cao; Daniel Robinson; Shanker Kalyana-Sundaram; Christina Huang; Sunita Shankar; Xiaojun Jing; Matthew Iyer; Ming Hu; Lee Sam; Catherine Grasso; Christopher A Maher; Nallasivam Palanisamy; Rohit Mehra; Hal D Kominsky; Javed Siddiqui; Jindan Yu; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Genome Res       Date:  2011-07       Impact factor: 9.043

2.  Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.

Authors:  Paula Paulo; Franclim R Ribeiro; Joana Santos; Diana Mesquita; Mafalda Almeida; João D Barros-Silva; Harri Itkonen; Rui Henrique; Carmen Jerónimo; Anita Sveen; Ian G Mills; Rolf I Skotheim; Ragnhild A Lothe; Manuel R Teixeira
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

Review 3.  Identification of cancer gene fusions based on advanced analysis of the human genome or transcriptome.

Authors:  Lu Wang
Journal:  Front Med       Date:  2013-06-26       Impact factor: 4.592

4.  Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.

Authors:  Lu Wang; Toru Motoi; Raya Khanin; Adam Olshen; Fredrik Mertens; Julia Bridge; Paola Dal Cin; Cristina R Antonescu; Samuel Singer; Meera Hameed; Judith V M G Bovee; Pancras C W Hogendoorn; Nicholas Socci; Marc Ladanyi
Journal:  Genes Chromosomes Cancer       Date:  2011-10-27       Impact factor: 5.006

Review 5.  Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue.

Authors:  Jian-Hua Luo; Silvia Liu; Ze-Hua Zuo; Rui Chen; George C Tseng; Yan P Yu
Journal:  Am J Pathol       Date:  2015-05-09       Impact factor: 4.307

6.  Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.

Authors:  Kirill Litovkin; Steven Joniau; Evelyne Lerut; Annouschka Laenen; Olivier Gevaert; Martin Spahn; Burkhard Kneitz; Sofie Isebaert; Karin Haustermans; Monique Beullens; Aleyde Van Eynde; Mathieu Bollen
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-18       Impact factor: 4.553

Review 7.  ETS gene fusions in prostate cancer.

Authors:  Jeremy P Clark; Colin S Cooper
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

8.  Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.

Authors:  Jianghua Wang; Yi Cai; Wendong Yu; Chengxi Ren; David M Spencer; Michael Ittmann
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

9.  A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis.

Authors:  Rolf I Skotheim; Gard O S Thomassen; Marthe Eken; Guro E Lind; Francesca Micci; Franclim R Ribeiro; Nuno Cerveira; Manuel R Teixeira; Sverre Heim; Torbjørn Rognes; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2009-01-19       Impact factor: 27.401

10.  Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts.

Authors:  B G Barwick; M Abramovitz; M Kodani; C S Moreno; R Nam; W Tang; M Bouzyk; A Seth; B Leyland-Jones
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.